We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

45 hedge funds and large institutions have $176M invested in Syndax Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

73% more capital invested

Capital invested by funds: $102M → $176M (+$73.9M)

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

4% less funds holding

Funds holding: 47 → 45 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
4
Increased
18
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.5M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$3.88M
3
SFM
Sphera Funds Management
Israel
+$2.19M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.62M
5
TAM
Tiverton Asset Management
Delaware
+$1.51M

Top Sellers

1
RG
Redmile Group
California
-$2.47M
2
Jennison Associates
Jennison Associates
New York
-$2.02M
3
Norges Bank
Norges Bank
Norway
-$244K
4
BIT
BlackRock Institutional Trust
California
-$224K
5
Millennium Management
Millennium Management
New York
-$137K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$358K +$3.92K +298 +1%
AA
27
ALPS Advisors
Colorado
$344K -$30.4K -2,310 -9%
LCM
28
Laurion Capital Management
New York
$305K +$264K +20,091 New
Morgan Stanley
29
Morgan Stanley
New York
$272K +$208K +15,819 +747%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$253K +$219K +16,641 New
Charles Schwab
31
Charles Schwab
California
$154K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$148K -$1.31K -100 -1%
UBS Group
33
UBS Group
Switzerland
$136K +$107K +8,126 +933%
Barclays
34
Barclays
United Kingdom
$85K +$63.6K +4,839 +606%
TA
35
Teachers Advisors
New York
$74K – – –
NFA
36
Nationwide Fund Advisors
Ohio
$43K – – –
AIG
37
American International Group
New York
$41.2K +$53 +4 +0.1%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$27K -$122K -9,300 -84%
Wells Fargo
39
Wells Fargo
California
$25K +$21.7K +1,648 New
SO
40
STRS Ohio
Ohio
$22K -$1.31K -100 -6%
Bank of America
41
Bank of America
North Carolina
$14K +$9.98K +759 +853%
Deutsche Bank
42
Deutsche Bank
Germany
$11K -$63.1K -4,796 -86%
Citigroup
43
Citigroup
New York
$6K -$1.14K -87 -18%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$4.87K +$1.78K +135 +73%
TCIM
45
TIAA CREF Investment Management
New York
$163 -$7.09K -539 -5%
RG
46
Redmile Group
California
– -$2.47M -250,830 Closed
Norges Bank
47
Norges Bank
Norway
– -$244K -24,768 Closed
Millennium Management
48
Millennium Management
New York
– -$137K -13,879 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$5K -505 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$2K -253 Closed
1
2
3

SNDX Hedge Fund Activity: Q3 2016 in Review

45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q3 2016, worth a combined $176M — up 73% from $102M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SNDX and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 18 added.

The largest buyer was Wellington Management Group, adding an estimated $11.5M. The largest seller was Redmile Group, exiting entirely with an estimated $2.47M sold.

  • 45 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q3 2016, down from 47 in Q2 2016.
  • Funds reported $176M of Syndax Pharmaceuticals stock for Q3 2016, up 73% quarter-over-quarter.
  • 4 funds opened new Syndax Pharmaceuticals positions in Q3 2016 and 6 closed out, a net change of -2 holders.
  • The largest Syndax Pharmaceuticals buyer in Q3 2016 was Wellington Management Group, an estimated $11.5M added.
  • The largest Syndax Pharmaceuticals seller in Q3 2016 was Redmile Group, an estimated $2.47M sold.

Based on aggregated 13F filings for Q3 2016.